AzTrials
AzTrials

MyopiaNCT06913972

A Comparative Analysis of Myopia Prevalence Among Madarsa Students vs. Non-Madarsa Students in Sukkur

An observational study of Myopia, run by Superior University at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Myopia (nearsightedness) has become a major global health concern, particularly among students, due to factors such as prolonged screen time, close-up work, and limited outdoor activities. Read more about this study

Who is it for?
Ages 5 to 20 years
Conditions the study is for
Myopia
How many people
364 participants
Where
1 sitePakistan
Study dates
20 Mar 2025to 20 Feb 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 20 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: To compare the prevalence of myopia among Madarsaand schoolstudents in Sukkur.

Who may be able to join

  • Students aged 5-20 years.[18]
  • Students of Sukkur enrolled in either Madarsa or schools.
  • Parents or guardians who understand and sign the informed consent form.
  • Students who are willing to undergo an eye examination and complete the research

Who cannot join

  • Students with known systemic diseases or eye conditions (e.g., cataracts, retinal diseases) that could influence the assessment of myopia.
  • Students who have had corrective eye surgery (e.g., LASIK) or those who have worn contact lenses or glasses for less than 3 months.
  • Students unable to participate due to language barriers or other communincation difficulties
  • Students with neurological conditions affecting vision
  • Students unable to cooperate with visual acuity testing due to cognitive impairments"

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Al Shifa trust eye Hospital

    Sukkur, Sindh

Other trials in Pakistan

About this study

Myopia (nearsightedness) has become a major global health concern, particularly among students, due to factors such as prolonged screen time, close-up work, and limited outdoor activities. In regions like Sukkur, Pakistan, the educational environments and lifestyles of students in Madarsas (religious schools) differ significantly from those in non-Madarsa (regular) schools, potentially influencing the prevalence of myopia. This comparative cross-sectional study aims to assess and compare the prevalence of myopia among Madarsa and non-Madarsa students in Sukkur.

Read the detailed description

The study will be conducted at Al Shifa Trust Eye Hospital over six months, involving students aged 5-20 years. Informed consent will be obtained from parents or guardians, and a structured questionnaire will collect data on lifestyle factors such as time spent on near work, outdoor activities, family history of refractive errors, and the use of corrective eyewear. Visual acuity and refractive errors will be assessed using standard eye charts, cycloplegic refraction, and measurements of keratometry, biometry, and axial length. The data will be analyzed using descriptive statistics, including frequencies, means, and standard deviations, with normality tests applied to continuous variables. Chi-square tests and Independent t-tests will be used for comparative analysis, while logistic regression will assess risk factors associated with myopia. The study will help determine the prevalence of myopia and its contributing factors in these student populations, informing potential interventions.

Conditions
Myopia
Medical subject headings
Myopia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. refraction

    In the eye, refraction is the bending of light rays as they pass through the cornea and lens, focusing them onto the retina for clear vision

    Measured: 12 Months

  2. auto-refractometer

    An auto-refractometer is a device used in eye exams to objectively measure a person's refractive error and determine the prescription needed for glasses or contact lenses, by analyzing how light reflects off the eye

    Measured: 12 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Apr 2025
  2. Study start20 Mar 2025
  3. Primary completion20 Jun 2025 (estimated)
  4. Study completion20 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
364 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06913972
Sponsor's protocol ID
MSRSW/Batch-Fall23/812
Status last verified
Mar 2025
First submitted
29 Mar 2025
Last updated
6 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Myopia, run by Superior University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 6 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

refraction (time frame: 12 Months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in